Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MCAR -- Ignore unavailable to you. Want to Upgrade?

To: stock4U who wrote (455)	11/28/1999 9:12:00 AM
From: LORD ERNIE	Read Replies (1) \| Respond to of 467

Big activity after market (more than 100k) BUT big difference in price. Last price 3 7/32 and a few minutes before $4.00

To: stock4U who wrote (455)	12/13/1999 6:17:00 PM
From: LORD ERNIE	Read Replies (1) \| Respond to of 467

MedCare Signs Agreement with Largest Manager of US Not-For-Profit Hospitals-Quorum Health Resources,LLC OAK BROOK, IL., Dec 13, 1999 (BUSINESS WIRE) -- MedCare Technologies, Inc. (NASDAQ: MCAR) announced today that it has signed a Strategic Service Partner Agreement with Quorum Health Resources, LLC, the largest manager of not-for-profit hospitals in the United States. This Agreement designates the MedCare Program as the primary provider of hospital based programs providing conservative treatment of urinary incontinence for its affiliated facilities. Quorum Health Resources manages approximately 214 hospitals and provides consulting services to more than 180 additional hospitals and has operations in 44 states and the District of Columbia. Quorum Health Resource's Strategic Partner Program is designed to identify companies in designated service areas and to partner with such companies to provide access to these services at a competitive price to its affiliated facilities. There are presently 44 such Strategic Service Partner relationships in place. "Since launching our new business hospital model, this is the most significant partnership we have put in place," said Jeff Aronin, President and Chief Executive Officer. "This three-year agreement clearly demonstrates the credibility and interest level that our Program has achieved in the hospital market. We believe that the signing of this agreement provides us with an excellent opportunity to pursue additional national agreements, maintain our market leadership position and enhance our overall marketing efforts. Furthermore, it should allow us to grow and expand our incontinence treatment business at a faster pace and create additional opportunities for our RxSheets.com business." Based on studies, it is estimated that incontinence affects upwards of 25 million people in North America. The MedCare Program is offered as a comprehensive continually supported program that provides an effective, non-intrusive treatment for sufferers of incontinence. MedCare provides the equipment, technology and training to the treatment site, as well as, ongoing support through its clinical and billing divisions. The training is all-inclusive in order for a hospital to promote a successful program, including proven protocols for equipment operation, community education, billing, managed care and outcomes. In addition, the Company offers a variety of financing options to the hospital through a plan developed with American Express Equipment Finance. MedCare Technologies, Inc. is a healthcare technology service company that focuses on under-served high growth markets. The Company began by developing the MedCare Program, now the nations leading conservative therapy for treating urinary incontinence, a hidden health condition that, at approximately $26 billion, costs more than diabetes and bypass surgery combined. The Company also recently launched RxSheets.com (www.rxsheets.com), which offers a wide array of compelling and focused information and services, including drug sample requests for physicians, drug protocols and studies, research information, and other pertinent aspects of the $270 billion worldwide pharmaceutical market This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, changes in insurance reimbursement, economic conditions, the impact of competition and pricing, government regulation, and other risks defined in this document and in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.